Viroclinics Biosciences - Gilde Healthcare

Viroclinics Biosciences

Private Equity

Rotterdam, The Netherlands
Boston, MA, USA

Contract Research
Since: 2013
Exit: 2017
Private Equity

Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.

Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.

More Viroclinics Biosciences news

Gilde Healthcare exits Viroclinics Biosciences

d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the

Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC